Technology and Commercial Assessment of a Tissue Regenerating Drug in the Regenerative Medicine Market

Technology and Commercial Assessment of a Tissue Regenerating Drug in the Regenerative Medicine Market

Bibliographic Details
Main Author: Webber, Nicholas R.
Language:English
Published: Case Western Reserve University School of Graduate Studies / OhioLINK 2014
Subjects:
Biology
Bone Marrow Transplant
STEP
Liver Resection
Ulcerative Colitis
PGDH
PGDH-15
Prostaglandins
Stem Cells
Regenerative Medicine
Online Access:http://rave.ohiolink.edu/etdc/view?acc_num=case1402249985
id ndltd-OhioLink-oai-etd.ohiolink.edu-case1402249985
record_format oai_dc
spelling ndltd-OhioLink-oai-etd.ohiolink.edu-case14022499852021-08-03T06:25:18Z Technology and Commercial Assessment of a Tissue Regenerating Drug in the Regenerative Medicine Market Webber, Nicholas R. Biology Bone Marrow Transplant STEP Liver Resection Ulcerative Colitis PGDH PGDH-15 Prostaglandins Stem Cells Regenerative Medicine Sanford "Sandy" Markowitz, MD, PhD, the Markowitz-Ingalls Professor of Cancer at the Case Western Reserve (CWRU) School of Medicine and practicing physician at University Hospitals of Cleveland (UH), is currently developing a first-in-class tissue-regenerating drug (TRD). TRD has the potential to benefit patients across a number of indications including liver surgery, bone marrow transplants, and ulcerative colitis attacks. TRD inhibits 15-prostaglandin dehydrogenase (15-PGDH), a prostaglandin-inhibiting enzyme, and enhances tissue regeneration in various tissue types. TRD is in the preclinical stage of development and the efficacies of each of its indications are being explored in vitro and in vivo by Dr. Markowitz and his team of researchers at CWRU. The purpose of this thesis is to analyze TRD's potential to enhance the standard of care and to navigate the commercial and regulatory landscapes over a variety ofpotential indications. 2014-08-29 English text Case Western Reserve University School of Graduate Studies / OhioLINK http://rave.ohiolink.edu/etdc/view?acc_num=case1402249985 http://rave.ohiolink.edu/etdc/view?acc_num=case1402249985 unrestricted This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws.
collection NDLTD
language English
sources NDLTD
topic Biology
Bone Marrow Transplant
STEP
Liver Resection
Ulcerative Colitis
PGDH
PGDH-15
Prostaglandins
Stem Cells
Regenerative Medicine
spellingShingle Biology
Bone Marrow Transplant
STEP
Liver Resection
Ulcerative Colitis
PGDH
PGDH-15
Prostaglandins
Stem Cells
Regenerative Medicine
Webber, Nicholas R.
Technology and Commercial Assessment of a Tissue Regenerating Drug in the Regenerative Medicine Market
author Webber, Nicholas R.
author_facet Webber, Nicholas R.
author_sort Webber, Nicholas R.
title Technology and Commercial Assessment of a Tissue Regenerating Drug in the Regenerative Medicine Market
title_short Technology and Commercial Assessment of a Tissue Regenerating Drug in the Regenerative Medicine Market
title_full Technology and Commercial Assessment of a Tissue Regenerating Drug in the Regenerative Medicine Market
title_fullStr Technology and Commercial Assessment of a Tissue Regenerating Drug in the Regenerative Medicine Market
title_full_unstemmed Technology and Commercial Assessment of a Tissue Regenerating Drug in the Regenerative Medicine Market
title_sort technology and commercial assessment of a tissue regenerating drug in the regenerative medicine market
publisher Case Western Reserve University School of Graduate Studies / OhioLINK
publishDate 2014
url http://rave.ohiolink.edu/etdc/view?acc_num=case1402249985
work_keys_str_mv AT webbernicholasr technologyandcommercialassessmentofatissueregeneratingdrugintheregenerativemedicinemarket
_version_ 1719436291280470016

Similar Items